Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLP
2051
One Liberty Properties
OLP
$530M
| $3.18M | ﹤0.01% |
143,963
+79,282
| +123% | +$1.89M |
|
2052
Arcus Biosciences
RCUS
$3.92B
| $3.18M | ﹤0.01% |
+205,941
| New | +$3.43M |
|
2053
PUT
Bristol-Myers Squibb
BMY
$138B
| $3.16M | ﹤0.01% |
50,000
-67,400
| -57% | -$4.34M |
|
|
WAAS
2054
DELISTED
AquaVenture Holdings Limited
WAAS
| $3.16M | ﹤0.01% |
254,476
+219,215
| +622% | +$3.08M |
|
2055
Skywest
SKYW
$3.92B
| $3.15M | ﹤0.01% |
57,969
+26,790
| +86% | +$1.48M |
|
2056
RE/MAX Holdings
RMAX
| $3.14M | ﹤0.01% |
51,935
-253,448
| -83% | -$13.3M |
|
2057
UDR
UDR
$12.2B
| $3.14M | ﹤0.01% |
+88,134
| New | +$3.1M |
|
2058
MGE Energy Inc
MGEE
$3B
| $3.14M | ﹤0.01% |
55,942
+18,498
| +49% | +$1.05M |
|
|
CCT
2059
DELISTED
Corporate Capital Trust, Inc.
CCT
| $3.13M | ﹤0.01% |
+185,434
| New | +$2.96M |
|
2060
Tredegar Corp
TG
$271M
| $3.12M | ﹤0.01% |
173,807
+668
| +0.4% | +$12K |
|
|
BHVN
2061
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.12M | ﹤0.01% |
120,979
-155,471
| -56% | -$4.65M |
|
2062
Digital Turbine
APPS
$1.31B
| $3.12M | ﹤0.01% |
1,549,547
+1,238,351
| +398% | +$2.69M |
|
|
AKRX
2063
DELISTED
Akorn Inc
AKRX
| $3.11M | ﹤0.01% |
166,263
+132,183
| +388% | +$3.58M |
|
2064
Haverty Furniture Companies
HVT
$425M
| $3.11M | ﹤0.01% |
154,242
+139,384
| +938% | +$2.99M |
|
2065
Alarm.com
ALRM
$2.78B
| $3.1M | ﹤0.01% |
82,250
-286,677
| -78% | -$10.8M |
|
2066
Valvoline
VVV
$4.18B
| $3.1M | ﹤0.01% |
140,237
+118,120
| +534% | +$2.81M |
|
|
SLCA
2067
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.09M | ﹤0.01% |
121,163
-1,057,102
| -90% | -$32.4M |
|
2068
HubSpot
HUBS
$11.8B
| $3.08M | ﹤0.01% |
28,441
+24,258
| +580% | +$2.53M |
|
2069
VanEck Gold Miners ETF
GDX
$31.9B
| $3.08M | ﹤0.01% |
139,940
-696,720
| -83% | -$15.7M |
|
|
DBVT
2070
DBV Technologies
DBVT
$913M
| $3.07M | ﹤0.01% |
13,326
+11,912
| +842% | +$2.82M |
|
2071
Amdocs
DOX
$6.5B
| $3.07M | ﹤0.01% |
46,030
-453,057
| -91% | -$30.5M |
|
|
BLD
2072
DELISTED
TopBuild
BLD
| $3.07M | ﹤0.01% |
40,123
-18,763
| -32% | -$1.42M |
|
|
MZOR
2073
CALL
DELISTED
Mazor Robotics Ltd.
MZOR
| $3.07M | ﹤0.01% |
+50,000
| New | +$3.14M |
|
|
CTIC
2074
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.07M | ﹤0.01% |
+786,583
| New | +$2.77M |
|
|
PDS
2075
Precision Drilling
PDS
$1.11B
| $3.06M | ﹤0.01% |
+55,279
| New | +$3.63M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.